The latest innovations in ophthalmic care for glaucoma patients

Conferences|GLAUCOMA 360

Ora Chief Medical Officer Gustavo De Moraes, MD, PhD, MPH, speak with Ophthalmology Times®' Sheryl Stevenson to discuss some of the cutting-edge advancements in therapies and diagnostics for the treatment of glaucoma patients.

Related Videos
Related Content

LaZrPlastique: The non–cutting edge over LASIK

March 22nd 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

The evolution of corneal transplantation surgery

March 21st 2023

Impact of prior authorization for cataract surgery

August 16th 2021

CDC gives update on VIM-GES-CRPA outbreak associated with artificial tears

March 17th 2023

Oculis completes enrollment in Phase 3 OCS-01 OPTIMIZE trial

March 16th 2023

LaZrPlastique: The non–cutting edge over LASIK

March 22nd 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

The evolution of corneal transplantation surgery

March 21st 2023

Impact of prior authorization for cataract surgery

August 16th 2021

CDC gives update on VIM-GES-CRPA outbreak associated with artificial tears

March 17th 2023

Oculis completes enrollment in Phase 3 OCS-01 OPTIMIZE trial

March 16th 2023

LaZrPlastique: The non–cutting edge over LASIK

March 22nd 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

The evolution of corneal transplantation surgery

March 21st 2023

Impact of prior authorization for cataract surgery

August 16th 2021

CDC gives update on VIM-GES-CRPA outbreak associated with artificial tears

March 17th 2023

Oculis completes enrollment in Phase 3 OCS-01 OPTIMIZE trial

March 16th 2023
© 2023 MJH Life Sciences

All rights reserved.